| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,419 | 10,992 | 11,269 | 11,802 | | Cost of Revenue | 7,360 | 7,903 | 7,512 | 7,753 | | | Gross Profit | (2,059) | 3,089 | 3,757 | 4,049 | | | Operating Expenses | | Research Development | 109 |
-
|
-
|
-
| | Selling General and Administrative | 3,788 | 4,507 | 4,267 | 3,993 | | Non Recurring |
-
| 9,961 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,838) | (11,379) | (510) | 56 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 88 | 1 | 16 | 159 | | Earnings Before Interest And Taxes | (1,750) | (11,378) | (494) | 215 | | Interest Expense | 222 | 173 | 177 | 196 | | Income Before Tax | (1,972) | (11,551) | (671) | 19 | | Income Tax Expense |
-
| 643 | (251) | (76) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,972) | (12,194) | (420) | 95 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,972) | (12,194) | (420) | 95 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,972) | ($12,194) | ($420) | $95 |
|
0.02% Nasdaq 0.00%
Income Statement
